Natural Killer T Cell Function in Lymphoma Patients
Biomolecules · 20.05.2026 · 16 (5) · 749
DOI: 10.3390/biom16050749 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 20.05.2026. Verfasst von Roshanak Derakhshandeh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21202, USA. Hauptthemen laut MEDLINE: Natural Killer T-Cells, Lymphoma. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, TEDCO, NIH.
Abstract (Originalsprache)
Natural killer T (NKT) cells bridge innate and adaptive immune responses and play a critical role in anti-tumor immunity. The goal of the study was to assess NKT cell and T cell function in lymphoma patients and to investigate whether specific cytokines correlate with outcomes and/or immune cell function. Patient diagnoses were confirmed by histology. NKT and T cell number and function were assessed by flow cytometry and stimulation with artificial antigen-presenting cells (aAPCs) followed by ELISA and quantitative RT-PCR (qPCR). Cytokine expression levels were compared using online databases, and protein levels in the plasma were assessed by ELISA. NKT cell activation, indicated by at least 1.5-fold IFN-γ induction over baseline following stimulation, was detected in 82% of healthy donors, compared to 44% of lymphoma patients. Lymphoma patients have significantly higher levels of circulating pro- and anti-inflammatory cytokines IL-10, IL-6, and Sema4D as compared to healthy donors. In addition, NKT cell function in the blood correlated with NKT cell function in the bone marrow in lymphoma patients. We found that aAPC-qPCR can be used to quickly assess immune cell function in cancer patients. Circulating NKT cell function positively correlated with bone marrow NKT cell function, suggesting that circulating NKT responses reflect systemic immune competence. Outcome-associated transcriptomic analyses showed that lower expression of TGF-β, IL-6, IL-10, and IFN-γ mRNA correlated with poorer clinical outcomes, whereas higher Sema4D expression was associated with worse prognosis, identifying Sema4D as a potential immunologic biomarker linked to disease progression and immune dysfunction in B cell lymphoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21202, USA.
- Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD 21201, USA.
- Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, MD 21201, USA.
- Department of Oncology and Diagnostic Sciences, School of Dentistry, Baltimore, MD 21201, USA.
- Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21202, USA.
ORCID-Profile: Emmanuel B Asiedu, Rania H Younis, Amy S Kimball, Tonya J Webb
Förderung
- NCI NIH HHS
- TEDCO
- NIH
- Maryland Department of Health
- Mike Slive Foundation
Zitieren
APA
Derakhshandeh, R., Lee, M. S., Zhu, Y., Asiedu, E. B., Reader, J., Younis, R. H., Kimball, A. S., Glynn, N., Kallen, M., & Webb, T. J. (2026). Natural Killer T Cell Function in Lymphoma Patients. Biomolecules, 16(5), 749. https://doi.org/10.3390/biom16050749
Vancouver
Derakhshandeh R, Lee MS, Zhu Y, Asiedu EB, Reader J, Younis RH, et al. Natural Killer T Cell Function in Lymphoma Patients. Biomolecules. 2026;16(5):749. doi:10.3390/biom16050749
BibTeX
@article{Derakhshandeh2026,
author = {Derakhshandeh, Roshanak and Lee, Michael S and Zhu, Yuyi and Asiedu, Emmanuel B and Reader, Jocelyn and Younis, Rania H and Kimball, Amy S and Glynn, Nicole and Kallen, Michael and Webb, Tonya J},
title = {Natural Killer T Cell Function in Lymphoma Patients},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {5},
pages = {749},
doi = {10.3390/biom16050749}
}
EUVIMED